Centaurus Financial’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-1,041
| Closed | -$143K | – | 855 |
|
2024
Q2 | $143K | Sell |
1,041
-8
| -0.8% | -$1.1K | 0.01% | 691 |
|
2024
Q1 | $144K | Buy |
1,049
+10
| +1% | +$1.37K | 0.01% | 688 |
|
2023
Q4 | $141K | Sell |
1,039
-224
| -18% | -$30.4K | 0.01% | 676 |
|
2023
Q3 | $154K | Sell |
1,263
-30
| -2% | -$3.66K | 0.01% | 634 |
|
2023
Q2 | $164K | Sell |
1,293
-931
| -42% | -$118K | 0.01% | 616 |
|
2023
Q1 | $287K | Sell |
2,224
-750
| -25% | -$96.8K | 0.02% | 553 |
|
2022
Q4 | $390K | Buy |
2,974
+1,181
| +66% | +$155K | 0.04% | 423 |
|
2022
Q3 | $210K | Sell |
1,793
-129
| -7% | -$15.1K | 0.02% | 606 |
|
2022
Q2 | $226K | Buy |
1,922
+237
| +14% | +$27.9K | 0.02% | 573 |
|
2022
Q1 | $220K | Sell |
1,685
-134
| -7% | -$17.5K | 0.02% | 638 |
|
2021
Q4 | $278K | Sell |
1,819
-655
| -26% | -$100K | 0.02% | 591 |
|
2021
Q3 | $400K | Sell |
2,474
-635
| -20% | -$103K | 0.03% | 475 |
|
2021
Q2 | $509K | Buy |
3,109
+1,667
| +116% | +$273K | 0.04% | 428 |
|
2021
Q1 | $217K | Buy |
1,442
+26
| +2% | +$3.91K | 0.02% | 577 |
|
2020
Q4 | $215K | Sell |
1,416
-135
| -9% | -$20.5K | 0.02% | 537 |
|
2020
Q3 | $210K | Sell |
1,551
-99
| -6% | -$13.4K | 0.03% | 442 |
|
2020
Q2 | $226K | Buy |
1,650
+7
| +0.4% | +$959 | 0.03% | 397 |
|
2020
Q1 | $177K | Sell |
1,643
-1,961
| -54% | -$211K | 0.04% | 365 |
|
2019
Q4 | $434K | Buy |
3,604
+1,237
| +52% | +$149K | 0.06% | 332 |
|
2019
Q3 | $236K | Buy |
2,367
+545
| +30% | +$54.3K | 0.04% | 383 |
|
2019
Q2 | $199K | Buy |
1,822
+1,661
| +1,032% | +$181K | 0.03% | 423 |
|
2019
Q1 | $1.44K | Buy |
161
+16
| +11% | +$144 | 0.01% | 507 |
|
2018
Q4 | $2 | Buy |
145
+142
| +4,733% | +$2 | 0.01% | 407 |
|
2018
Q3 | $358 | Sell |
3
-4,077
| -100% | -$487K | 0.06% | 284 |
|
2018
Q2 | $448K | Buy |
4,080
+934
| +30% | +$103K | 0.06% | 327 |
|
2018
Q1 | $336K | Buy |
3,146
+233
| +8% | +$24.9K | 0.08% | 249 |
|
2017
Q4 | $311K | Buy |
+2,913
| New | +$311K | 0.08% | 238 |
|